UroGen Pharma Ltd.
URGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001668243
In the last 90 days, UroGen Pharma Ltd. insiders filed 0 open-market purchases and 4 sales; 190 institutions reported holding it in 13F filings for Q2 2026, worth $1.56B in total; ARK Invest is the only superinvestor holding it.
Members of Congress who traded URGN
No member of Congress has reported a trade in UroGen Pharma Ltd. since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.